An interventional study of Educational Video in Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI), Anxiety and Patient Education Materials, sponsored by Tobias Schreiber. Not yet recruiting at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-23.
Sponsored by Tobias Schreiber · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 92 studies in Acute Coronary Syndrome with a site in Germany — 8 open to participants now, 13 under way, 1 of them phase 3. Acute Coronary Syndrome · Germany.
Among the 92 studies in Acute Coronary Syndrome with a site in Germany, this one is the 49th largest by planned enrollment of the 59 interventional ones that give a count, is one of 2 that started in 2026, is one of 15 with no phase, reaches primary completion later than 8 of the 12 other live ones, and was the 90th registered.
1,491 studies on the registry are indexed under Acute Coronary Syndrome; 272 are open to participants now.
Browse Acute Coronary Syndrome studies →8 of the 92 studies in Acute Coronary Syndrome with a site in Germany are open now. Recruiting first, the newest first:
Stephan Baldus · Sites in Germany
Ages 18+
University of Leipzig · Sites in Germany
Ages 18+
CoreAalst BV · Sites in Germany, Belgium, China and 5 more countries
Ages 18–85
North Karelia Central Hospital · Sites in Germany, Finland, France and 1 more country
Ages 18+
University Hospital Heidelberg · Sites in Germany
Ages 18+
A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →
Of the 195 Acute Coronary Syndrome studies recruiting now, 144 (74%) set no upper age limit and 19 (10%) stop at 75 or younger; 15 take children under 18; 15 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
92 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 4 · Phase 2 6 · Phase 3 23 · Phase 4 12
First in 2003; this study’s year is marked. 2 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 140 is below the median of 200 across 868 interventional studies indexed under Acute Coronary Syndrome.
Median enrollment 1,861 across the 59 interventional studies, 657 across the 33 observational. Of the 73 that completed or were terminated, 22 (30%) have results posted.
This tab as a report to print or save as PDF → With an account.
44 of 92 have an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with Tobias Schreiber as lead sponsor.
Tobias Schreiber has 1 study filed under Acute Coronary Syndrome — fewer than ten, so there is no comparison to draw.
4 of the studies in Acute Coronary Syndrome with a site in Germany that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07102628Phase 3Novartis PharmaceuticalsEvaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes | 2027-01-16 |
| NCT05540223Biotronik AGSafety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System | 2027-02 |
| NCT07091682Biotronik AGSafety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Treatment of Subjects With Long de Novo Lesions | 2027-06 |
| NCT07424482Tobias SchreiberEducational Video to Improve Understanding and Reduce Anxiety in Heart Attack Patients | 2027-09-01 |
Add all 4 to your calendar (.ics) → With an account.
Among the 92 studies in Acute Coronary Syndrome with a site in Germany, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Patients who are diagnosed with a heart attack are often confronted with an unexpected hospital admission and an urgent heart catheterization. In this stressful situation, anxiety is common and understanding of the procedure may be limited, even after standard verbal and written explanations.
This study investigates whether a short educational video, shown in addition to standard medical information, can help patients better understand the heart catheterization procedure and reduce anxiety before the intervention. Patients will be randomly assigned to receive either standard information alone or standard information plus the educational video.
The study will assess patients' understanding of the procedure, their level of anxiety, and their satisfaction with the information provided. The results may help improve patient education and support in acute cardiac care settings.
Patients admitted with acute coronary syndrome require urgent heart catheterization under stressful and unfamiliar circumstances. Anxiety levels are often elevated, and the ability to process and retain medical information may be reduced. Standard patient education is typically provided verbally and in written form, but time constraints and the acute clinical setting may limit its effectiveness.
The purpose of this randomized controlled study is to evaluate the effect of a short, standardized educational video shown in addition to standard care. The video is designed to provide structured information about the heart catheterization procedure, including its purpose, key steps, typical visual impressions, and immediate post-procedural care, without minimizing potential risks. The intervention is intended to complement, not replace, routine physician-led informed consent.
Eligible patients with acute coronary syndrome who are undergoing heart catheterization for the first time will be enrolled and randomly assigned to either standard information alone or standard information plus the educational video.
The primary objective is to determine whether the educational video improves patients' understanding of the procedure. Secondary objectives include assessing its effect on anxiety levels and patient satisfaction.
By focusing on an easily scalable educational intervention, this study aims to provide evidence for improving patient-centered communication in acute cardiac care. If effective, the approach may be implemented into routine clinical practice.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Other: Educational Video
Participants assigned to the intervention group will receive standard verbal and written medical information according to routine clinical practice. In addition, they will watch a short, standardized educational video explaining the heart catheterization procedure, including its purpose, main steps, typical visual impressions, and immediate post-procedural care. The video is intended to complement, not replace, physician-led informed consent.
Patient knowledge
Multiple Choice test before coronary angiography. A higher test result indicates better understanding.
Time frame: Within 24 hours before coronary angiography
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Jul 2026; primary completion for Sep 2027, 14 months later.
Of 213 non-industry interventional studies with no phase under Acute Coronary Syndrome, half reached primary completion within 34 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 46. This study's planned 14 months is below that.
Counting every sponsor, half of 228 studies reached it within 34 months; a quarter within 17 and three quarters within 46.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.